Literature DB >> 19566872

Combined biliary and gastric bypass procedures as effective palliation for unresectable malignant disease.

Christopher D Mann1, Sarah C Thomasset, Nicholas A Johnson, Guiseppe Garcea, Christopher P Neal, Ashley R Dennison, David P Berry.   

Abstract

BACKGROUND: Although endoscopic treatment of jaundice is increasingly used in the palliation of unresectable malignant disease, surgical bypass still has a role to play in this setting. This study aimed to reappraise the short-term and long-term results of combined biliary/gastric bypass (hepaticojejunostomy and gastrojejunostomy) as palliation for unresectable malignant disease.
METHODS: All patients undergoing simultaneous biliary and gastric bypass procedures for unresectable malignant disease between August 2000 and January 2006 were identified and outcomes reviewed.
RESULTS: One hundred and two patients underwent open surgical biliary drainage procedures for palliation of malignant disease. Underlying malignant disease included pancreatic carcinoma (n = 88), duodenal adenocarcinoma (n = 6) and distal cholangiocarcinoma (n = 3). Thirty-one of the patients underwent a planned palliative bypass procedure, the remainder being carried out after unresectable disease was identified at laparotomy. Postoperative mortality and morbidity rates were higher in the group undergoing planned bypass. During follow up, two patients developed recurrent jaundice that required transhepatic stenting and two patients developed late gastric outlet obstruction requiring refashioning of the gastrojejunostomy.
CONCLUSION: Combined surgical biliary and gastric bypass achieved effective palliation of jaundice and gastric outlet obstruction until death in >95% of patients in this series. It remains first-line therapy in patients identified as having unresectable disease at laparotomy.

Entities:  

Mesh:

Year:  2009        PMID: 19566872     DOI: 10.1111/j.1445-2197.2008.04798.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  9 in total

1.  Is intraoperative confirmation of malignancy during pancreaticoduodenectomy mandatory?

Authors:  Giuseppe Garcea; Matthew S Metcalfe; David P Berry; Gavin S Robertson; David M Lloyd; Ashley R Dennison
Journal:  J Gastrointest Surg       Date:  2011-10-28       Impact factor: 3.452

Review 2.  Drainage and bypass procedures for palliation of malignant diseases of the upper gastrointestinal tract.

Authors:  M T Huggett; P Ghaneh; S P Pereira
Journal:  Clin Oncol (R Coll Radiol)       Date:  2010-11       Impact factor: 4.126

3.  Biliary stenting versus surgical bypass for palliation of periampullary malignancy.

Authors:  Mehrdad Nikfarjam; Andrew K Hadj; Vijayaragavan Muralidharan; Niall Tebbutt; Michael A Fink; Robert M Jones; Graham Starkey; Rhys B Vaughan; Alexander W Marshall; Christopher Christophi
Journal:  Indian J Gastroenterol       Date:  2012-11-16

4.  Current and emerging therapies for the treatment of pancreatic cancer.

Authors:  Rebecca A Moss; Clifton Lee
Journal:  Onco Targets Ther       Date:  2010-09-07       Impact factor: 4.147

5.  Surgical bypass and permanent iodine-125 seed implantation vs. surgical bypass for the treatment of pancreatic head cancer.

Authors:  Zhenjiang Zheng; Yinglong Xu; Shu Zhang; Guangchun Pu; Chi Cui
Journal:  Oncol Lett       Date:  2017-06-30       Impact factor: 2.967

6.  Influence of peritoneal carcinomatosis on perioperative outcome in palliative gastric bypass for malignant gastric outlet obstruction - a retrospective cohort study.

Authors:  Jan Bednarsch; Zoltan Czigany; Daniel Heise; Henning Zimmermann; Joerg Boecker; Tom Florian Ulmer; Ulf Peter Neumann; Christian Klink
Journal:  World J Surg Oncol       Date:  2020-01-31       Impact factor: 2.754

7.  Double bypass for inoperable pancreatic malignancy at laparotomy: postoperative complications and long-term outcome.

Authors:  F Ausania; A E Vallance; D M Manas; J M Prentis; C P Snowden; S A White; R M Charnley; J J French; B C Jaques
Journal:  Ann R Coll Surg Engl       Date:  2012-11       Impact factor: 1.891

8.  Total laparoscopic Roux-en-Y cholangiojejunostomy for the treatment of biliary disease.

Authors:  Dexing Chen; Andong Zhu; Zhibo Zhang
Journal:  JSLS       Date:  2013-06-25       Impact factor: 2.172

9.  Double Stenting for Malignant Biliary and Duodenal Obstruction: A Systematic Review and Meta-Analysis.

Authors:  Anna Fábián; Renáta Bor; Noémi Gede; Péter Bacsur; Dániel Pécsi; Péter Hegyi; Barbara Tóth; Zsolt Szakács; Áron Vincze; István Ruzsics; Zoltán Rakonczay; Bálint Erőss; Róbert Sepp; Zoltán Szepes
Journal:  Clin Transl Gastroenterol       Date:  2020-04       Impact factor: 4.396

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.